This inventor holds 1 USPTO granted patent. Top assignee: National Tsing Hua University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Pei-Feng Liu: Innovator in ATG4-Related Disorders
Introduction
Pei-Feng Liu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical treatments, particularly concerning ATG4-related disorders. His innovative approach has led to the development of a unique method for treating these disorders.
Latest Patents
Pei-Feng Liu holds a patent titled "Method for the treatment of ATG4-related disorders." This invention focuses on a method of treating an ATG4B-related disorder by administering an effective amount of tioconazole. Additionally, it outlines a method for increasing a subject's responsiveness to cancer therapy by inhibiting ATG4B activity in cells. The patent also describes a method for enhancing or inducing responses in cancer cells, such as cytotoxicity and chemosensitivity, through the administration of tioconazole.
Career Highlights
Pei-Feng Liu is affiliated with National Tsing Hua University, where he continues to advance research in his field. His work has garnered attention for its potential impact on cancer treatment and the management of ATG4-related disorders.
Collaborations
Pei-Feng Liu has collaborated with notable colleagues, including Kun-Lin Tsai and Lee-Wei Yang, who contribute to the research and development of innovative medical solutions.
Conclusion
Pei-Feng Liu's contributions to the treatment of ATG4-related disorders highlight his role as an influential inventor in the medical field. His innovative methods have the potential to improve therapeutic outcomes for patients suffering from these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile